Intrinsiqq
Galenica logo

Galenica Quality Score

GALE.XSWX

⊜ Compare
Quality73

Valuation remains strong (avg 85/100), but business quality is pulling the composite down (avg 63/100).

Broad-market heuristics · Not a buy/sell signal

Valuation and growth

Earnings Multiple
80/100
24.3x

20–25x range, moderate premium

Cash Flow Multiple
90/100
18.0x

Under 20x cash flow, well covered

Revenue Growth
50/100
4.8%

2–5% CAGR, growing but slowly

Cash Flow Growth
100/100
13.5%

Above 10% CAGR, strong compounder

Business Quality & Capital Allocation

Share Dilution
60/100
0.2%

Mild dilution under 2%

Margin Trend
70/100
+0.3pp

Slight expansion, directionally positive

Capital Structure
60/100
CHF 128M

Net debt/FCF of 0.5x, manageable

2022
CHF 94.0M
CHF 233M
2023
CHF 116M
CHF 236M
2024
CHF 130M
CHF 236M
2025
CHF 116M
CHF 244M
CashDebt
Return on Capital
60/100
10.6%

10–15%, respectable returns

Customize WeightsPremiumUpgrade

Galenica (GALE.XSWX) quality: score, margins and returns

Galenica (GALE.XSWX) scores 73/100 on Intrinsiqq's quality score (a solid business), a weighted blend of 8 metrics each scored 0 to 100, on 5.5% operating margins and 10.6% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.

Frequently asked

Is Galenica (GALE.XSWX) a high-quality business?+

Galenica scores 73 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which rates it a solid business on these measures. Recent figures include a 5.5% operating margin and a 10.6% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.

What does Galenica's quality score measure?+

Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from GALE.XSWX's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Galenica scores well and where it falls behind.

What is Galenica's return on invested capital (ROIC)?+

Galenica earns about 10.6% on its invested capital, which is solid. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to GALE.XSWX's margins and growth on this scorecard to judge durability.

How profitable is Galenica?+

Galenica runs an operating margin of about 5.5% and a net margin of about 4.4%. Revenue has grown at roughly 1.9% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.

More on GALE.XSWX: Overview · DCF valuation · Dividend safety · Financials
How the market compares: US profitability statistics

Peers

Medical Distribution · Pick stocks to compare with GALE.XSWX

CompareIntrinsic value
SOON.XSWXSonova Holding AG
CHF 281.40-0.78%34
STMN.XSWXStraumann
CHF 97.66-0.08%55
LONN.XSWXLonza Group AG
CHF 663.19+1.68%17
SFZN.XSWXSiegfried Holding AG
CHF 75.05+1.42%41
AEVS.XSWXAevis Victoria SA
CHF 14.20-0.35%25
DOCM.XSWXDocMorris AG
CHF 15.94+7.20%26
TECN.XSWXTecan Group AG
CHF 243.00+0.16%35
YPSN.XSWXYpsomed Holding AG
CHF 400.90+1.96%54

Held by ETFs

GALE.XSWX is in 34 US ETFs. The largest of them, with GALE.XSWX's weight in each:

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing GALE.XSWX

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.